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Sympathetic neurons regulate GI motility, secretion, and blood flow, either directly, through actions on vascular smooth muscle, or indirectly, via pre-and postsynaptic inhibitory effects on enteric neurons (17, 27, 33, 48) . Prevertebral ganglia contain sympathetic postganglionic neurons that integrate synaptic inputs from a host of neuronal populations (17, 31, 50) and have fenestrated capillaries that permit access of bloodborne macromolecules such as circulating cytokines (3, 11) . These ganglia may therefore be exposed to elevated systemic cytokine concentrations during IBD flare-ups. This suggests that the immune system can modulate the sympathetic nervous system, and recent studies have strengthened the notion that the immune system can be modulated by sympathetic neurotransmitters (15) . These reciprocal interactions could have a significant impact of IBD pathogenesis. For example, a ␤ 3 -adrenoceptor agonist inhibited trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats, which suggests an immunomodulatory role for the sympathetic innervation of the GI tract (1, 44 -46, 52) . However, norepinephrine release is markedly reduced during colitis (7, 19, 20, 49) . Therefore, it is important to understand the mechanisms of defective sympathetic regulation during colitis, since reversing the inhibition of norepinephrine release may normalize function at uninflamed sites and restore an endogenous anti-inflammatory mechanism in the GI tract.
Voltage-gated Ca 2ϩ channels (VGCC) play a vital role in neurotransmitter release, since they open during membrane depolarization and allow Ca 2ϩ influx into nerve terminals, where it triggers synaptic vesicle fusion with the presynaptic membrane (9) . We hypothesized that inhibition of Ca 2ϩ entry via VGCC underlies impaired sympathetic release of norepinephrine during colitis. This hypothesis was tested by measuring 3 H-labeled norepinephrine release in the colons and small intestines of control mice and mice with dextran sulfate sodium (DSS)-induced colitis and by examining the effect of colitis on VGCC of neurons dissociated from mouse superior mesenteric ganglia (SMG) that innervate the colon and small intestine.
METHODS

Animals and materials.
Male CD-1 mice weighing 25-35 g were obtained from Charles River (Saint-Constant, QC, Canada). Experimental protocols were approved by the Queen's University Animal Care Committee and conformed to the Guidelines of the Canadian Council of Animal Care. Animals had access to standard laboratory chow and tap water ad libitum. All reagents were bought from Sigma Aldrich, St. Louis, MO, unless otherwise stated. Colonic inflammation was induced by administration of DSS (5% wt/vol; MP Biomedicals, Solon, OH) in drinking water for 5 days, followed by normal drinking water for 1-3 days (37, 54) . Control mice received normal drinking water for 6 -8 days. The DSS-treated mice were monitored daily for signs of distress, altered feeding and drinking habits, loose and/or bloody stool, and weight loss. Mice were deeply anesthetized by isoflurane inhalation and euthanized by cervical dislocation.
Assessment of inflammation. Segments of proximal colon and jejuna from control and DSS-treated mice were dissected, flash frozen in an Eppendorf tube in liquid nitrogen, and stored at Ϫ80°C for 7-14 days until assayed for myeloperoxidase (MPO) activity, a measure of neutrophil infiltration, as previously described (30) . Values are expressed as units of MPO activity per gram of tissue sample, where one unit of MPO is defined as the amount that degrades 1 mol of hydrogen peroxide per minute.
Measurement of norepinephrine release. Control or DSS-treated mice were euthanized following isoflurane anesthesia, and segments of the colon and jejunum were excised and placed in bubbled Krebs solution containing (in mmol/l) 126 NaCl, 5 KCl, 2.5 NaH 2PO4, 1.2 MgCl2, 2.5 CaCl2, 11 glucose, 25 NaHCO3, bubbled with 95% O2-5% CO2. Krebs solution also contained pargylline (30 M), a monoamine oxidase inhibitor. The colon or jejunum was opened, cleared of contents, and pinned out in a Sylgard (Dow-Corning)-lined petri dish for removal of the mucosa, which aids uptake of the radiolabeled norepinephrine. After separating the mucosa from the tissue, we cut the segments into two equal parts, placed in fresh Krebs for 10 min and then transferred to Krebs containing 1- [7,8- 3 H]norepinephrine (0.2 mol/l, 42 Ci/mmol, Amersham, Piscataway, NJ) for 60 min at 37°C. After the incubation phase the tissues were washed three times with normal Krebs at 37°C. To stimulate the release of the radiolabeled norepinephrine the tissues were transferred into wells containing high K ϩ Krebs solution (in mmol/l: 61 NaCl, 70 KCl, 2.5 NaH2PO4, 1.2 MgCl2, 2.5 CaCl2, 11 glucose, 25 NaHCO3, 0.03 pargylline) to depolarize nerve terminals. Aliquots of supernatant were removed 5 min after the introduction of the high K ϩ Krebs and every 10 min thereafter for 30 min. These samples (250 l) were added to 2 ml scintillation fluid (biodegradable counting scintillation fluid, Amersham) and the tritium amounts were measured with a liquid scintillation counter (Plate Chameleon, Bioscan, Washington, DC). At the conclusion of release measurements, tissues were blotted dry, weighed, and solubilized with 1 ml Soluene-350 tissue solubilizer (Perkin-Elmer, Waltham, MA) and neutralized with 50 l glacial acetic acid (17 M) per 3 ml. The solubilized tissue was then added to 3 ml scintillation fluid and the samples were analyzed to determine the total residual tritium content in each tissue sample. The released tritium (counts per minute) was expressed as a percentage of the total amount of tritium in the specific tissue.
Western blotting. Approximately 100 mg of distal colon was removed from control and DSS-treated mice. Tissue was then transferred to 500 l ice-cold lysis buffer and sonicated for 15 s. Following an additional 30 min of solubilization, the solution was centrifuged at 12,000 rpm for 1 min and an aliquot containing 10 g of total protein was removed and separated on a 10% polyacrylamide gel. The separated proteins were then electroblotted onto polyvinylidene difluoride membrane and immersed in 5% nonfat milk in PBS containing 0.05% Tween (PBST) for 1 h. The blot was washed with PBST and incubated overnight at 4°C in polyclonal rabbit anti-tyrosine hydroxylase antiserum (Millipore, Etobicoke, ON, Canada) at a 1:1,000 dilution in 5% nonfat milk (27) . After subsequent washes in PBST, the blot was incubated in donkey horseradish peroxidaselabeled secondary rabbit antibody (Jackson ImmunoResearch, Westgrove, PA) for 1 h, washed in PBST, and finally developed with a chemiluminescent substrate (Fisher Scientific, Ottawa, ON, Canada).
The blot was then stripped at 60°C for 1 h in 0.2 M glycine at pH 2.5 containing 0.05% Tween 20; washed briefly and then incubated for one h in a 1:20,000 dilution of anti-␤-actin antibody (Sigma, Canada). After 3 ϫ 10 min washes in PBST, the secondary antibody (1:10,000 peroxidase-conjugated AffiniPure donkey anti-mouse; Cedarlane, Burlington, ON, Canada) was added for 1 h. Following three final 10 min washes, the blot was developed, scanned, and analyzed via Image Pro (Media Cybernetics) to measure the integral optical density of individual bands.
Isolation of SMG neurons. The methods used for dissociating neurons were described previously (23) . Following a laparotomy, the SMG was quickly removed and placed in Hanks' buffered salt solution (HBSS; Invitrogen, Carlsbad, CA) maintained at 37°C. Ganglia were then washed with HBSS three times before being enzymatically dissociated by incubation for 25 min in collagenase (Type 1A) and bovine serum albumin (BSA; 6 mg/ml), and 15 min in trypsin (Type XII-S) and BSA (6 mg/ml)-containing HBSS. To neutralize the enzymatic activity of trypsin, 10% fetal calf serum (Invitrogen) was added. Single neurons were isolated by trituration through a series of fire-polished Pasteur pipettes of decreasing diameter. Following trituration, the cell suspension was centrifuged at 600 rpm for 5 min and the supernatant was discarded. Dissociated neurons were plated on laminin-coated (10 g/ml) glass coverslips and maintained overnight at 37°C and 5% CO 2 in Leibowitz medium supplemented with 24 mM NaHCO3, 10% FCS, 38 mM D-glucose, 2 mM L-glutamine, 5,000 IU penicillin and streptomycin, and 50 ng/ml nerve growth factor (Cedarlane, Burlington, ON, Canada).
Intracellular Ca 2ϩ imaging. Intracellular calcium concentration ([Ca 2ϩ ]i) measurements were recorded in isolated SMG neurons that were incubated in 2 M fura 2 acetoxymethylester (AM; dissolved in DMSO; Invitrogen) for 30 min at 37°C. Neurons were subsequently washed for 20 min with HEPES-buffered saline to remove the excess extracellular fura 2-AM and to allow for intracellular deesterification of the fluorophore. The saline solution was composed of (in mM) 140 NaCl, 10 HEPES, 10 glucose, 5 KCl, 2 CaCl2, 1 MgCl2, pH adjusted to 7.4 with NaOH. Coverslips were mounted in a recording chamber on an inverted microscope (Olympus IX71, Markham, ON, Canada) and superfused with this solution at room temperature (20 -22°C). Changes in [Ca 2ϩ ]i were measured with ImageMaster 5.0 software. The fura 2-AM-loaded cells were illuminated at 340 and 380 nm every second for 10 min with a DeltaRamV high-speed randomaccess monochromator and a Photometrics Cascade 512B CCD camera (Photon Technology International, London, ON, Canada). Regions of interest (ROI) were defined within the cytoplasm of neurons, from which the averaged pixel intensity within the ROI was calculated. Paired 340/380 fluorescence ratios of each ROI were calculated every second. [Ca 2ϩ ]i was measured as the ratio of the fluorescence signals obtained at 405 nm following excitation at 340 and 380 nm. To depolarize neurons and activate VGCC, neurons were superfused with saline solution containing (in mM): 75 NaCl, 10 HEPES, 10 glucose, 70 KCl, 2 CaCl2, 1 MgCl2, pH adjusted to 7.4 with NaOH for 1 min, followed by washout. To compare changes in [Ca 2ϩ ]i during depolarizations between cell populations, the peak change in 340/380 ratio was expressed as a percentage change of the baseline fluorescence prior to depolarization.
Patch-clamp recordings. All experiments were performed at room temperature. Patch pipettes were fabricated from borosilicate glass capillaries (Warner Instruments, Hamden, CT) and had resistances between 2 and 4 M⍀ when filled with internal solution of the following composition (in mM): 120 CsCl, 1 MgCl2, 4 MgATP, 0.3 NaGTP, 10 EGTA, 10 HEPES, pH adjusted to 7.2 with CsOH. A calculated liquid junction potential (Clampex Junction Potential Assistant) of 10 mV was digitally compensated. To achieve perforated patch configuration, pipettes were backfilled with internal solution containing amphotericin-B (50 g/ml, Sigma). After an acceptable access resistance was stably acquired (8 -15 M⍀), the cell membrane capacitance and series resistance were electronically compensated.
Voltage-clamp recording was performed by use of a Multiclamp 700B amplifier, and data were acquired at 10 kHz for analysis via a Digidata 1440A analog-to-digital converter and pClamp 10.1 software (all from MDS Analytical Technologies, Mississauga, ON, Canada).
Currents through VGCC were recorded using extracellular solution consisting of (in mM): 140 tetraethylammonium (TEA)-Cl, 2 MgCl2, 5 BaCl 2, 10 glucose, 10 HEPES (pH adjusted to 7.4 with TEA-OH). The perforated-patch current, carried by Ba 2ϩ through Ca 2ϩ channels (I Ca), was elicited by a series of command potentials from Ϫ60 to 35 mV for 100 ms in 5 mV steps (10 s intervals) from a holding potential of Ϫ100 mV. ICa was stable for at least 5 min before recordings commenced. Series resistances were compensated 80 -85%. The amplitude of inward currents was normalized to cell capacitance. To study the effects of specific Ca 2ϩ channel blockers, the membrane potential was stepped to 0 mV from a holding potential of Ϫ100 mV for 100 ms to elicit I Ca every 10 s before and during superfusion of antagonists. The steady-state inactivation of VGCCs was measured by depolarizing cells to a series of prepulse potentials from Ϫ100 to 20 mV for 500 ms followed by a command potential to 0 mV for 150 ms. Activation and inactivation curves were fitted with a single Boltzmann function of the form
Drug application. -Conotoxin GVIA and -conotoxin MVIIC were obtained from Tocris (Ellisville, MO). Neurons were superfused with 300 nM -conotoxin GVIA (N-type channel blocker), 10 M nifedipine (L-type blocker) and 300 nM -conotoxin MVIIC (N, P/Q type blocker). To determine the contribution of P/Q type channels to the total current, N-type channels were initially blocked with -conotoxin GVIA, followed by superfusion of -conotoxin MVIIC. The difference in inhibition caused by these two blockers was taken as an estimate of P/Q type current. In all cases, current inhibition was allowed to reach a steady state before the extent of inhibition was measured.
Real-time PCR. RNA was extracted from pooled superior mesenteric ganglia of two control and two DSS-treated mice using the Trizol method (Invitrogen Burlington, ON, Canada). cDNA was then reverse transcribed from 1 g of total RNA by use of Expand Reverse Transcriptase (Roche, Mississauga, ON, Canada) and oligo(dT) 12-18 primers (Invitrogen). Subsequently, real-time PCR was performed using a Roche Lightcycler and a Quantitech SYBRgreen PCR Kit (Qiagen, Mississauga, ON, Canada). The target to reference ratio was then calculated by use of the Relquant software (Roche). The following intron-spanning primers were used: GAPDH (NM_008084, 130-bp product) forward TAGACAAAATGGTGAAGGTCGG, reverse AGTTGAGGTCAATGAAGGGGT; CaV2.2 (NM_001042528, 124-bp product) forward AGCCCTCAGATCCCAGCA, reverse GC-CTCCTTCTTGCCCTCT.
Statistical analysis. Electrophysiological data were analyzed by using Clampfit 10 (MDS analytical technologies). Statistical analysis was performed and graphs were formatted with GraphPad Prism 5. N values refer to the number of neurons used in assays unless otherwise stated. Population data were expressed as means Ϯ SE. Population data were compared by Student's t-test for parametric data, the Mann-Whitney test for unparametric data, and two-way analysis of variance for current-voltage relation data. Statistical significance was reached when P Ͻ 0.05.
RESULTS
DSS colitis reduced norepinephrine release.
Previous studies using the TNBS and Trichinella spiralis models of GI inflammation in rats found that norepinephrine release was reduced during inflammation (7, 20, 49) . We examined whether a similar reduction in norepinephrine release occurred in the DSS model of colitis in mice. The colons of mice treated with DSS had well-characterized mucosal ulceration and significantly increased MPO activity compared with untreated controls [7. 2 Ϯ 0.6 (n ϭ 42) vs. 0.9 Ϯ 0.1 (n ϭ 27) units/mg; P Ͻ 0.001, unpaired t-test]. Norepinephrine release was measured from colonic segments of control mice and mice with DSS-induced colitis in response to stimulation with 70 mM extracellular K ϩ . Aliquots of supernatant were taken for measurement 5 min after the introduction of the high K ϩ Krebs and every 10 min thereafter for 30 min. The average release of labeled norepinephrine following stimulation in 70 mM K ϩ -containing saline was significantly reduced at each of the four time points measured in DSS-treated colons compared with controls ( Fig. 1A ; P Ͻ 0.05, Mann-Whitney test). Norepinephrine release was measured only at 25 min after stimulation in subsequent experiments.
One potential reason for reduced norepinephrine release during colitis is that colitis reduced the sympathetic innervation of the colon. We investigated this possibility by using Western blot to quantify the amount of tyrosine hydroxylase (TH) Fig. 1 . Colitis reduced the release of [ 3 H]norepinephrine from the colon. A: mean Ϯ SE data showing the depolarization-induced release of norepinephrine from colonic tissue samples from control and dextran sodium sulfate (DSS)-treated mice across various time points (n ϭ 12 for both groups, *P Ͻ 0.05, Mann-Whitney test). B: Western blots of protein samples to detect tyrosine hydroxylase (TH) and ␤-actin. Each lane represents TH quantity in a single colon, with corresponding ␤-actin blots. C: release of norepinephrine from the uninflamed jejunum was significantly inhibited during DSS colitis (n ϭ 6 for both groups, *P Ͻ 0.05, Mann-Whitney test).
immunoreactivity in the colons of control and inflamed mice (Fig. 1B) . Colitis caused a statistically significant increase in TH expression when normalized to ␤-actin expression (control: 1.5 Ϯ 0.4 vs. DSS: 5.2 Ϯ 1.1; P ϭ 0.046; n ϭ 3 colons from controls and 4 from DSS). These data indicate that it is very unlikely that colitis reduced tyrosine-immunoreactive sympathetic innervation of the colon. This is in agreement with a previous study of the submucosal plexus of mouse colon during TNBS colitis (27) but contrasts with the findings of Straub et al. (44) . We next examined the effect of colitis on norepinephrine release in the uninflamed jejunum of DSStreated mice. Despite very similar MPO activities in the jejuna of control mice and DSS-treated mice (MPO activity of control jejuna: 1.5 Ϯ 0.46 units/mg; DSS: 1.6 Ϯ 0.63 units/mg, P ϭ 0.93, unpaired t-test, n ϭ 6 each) the release of norepinephrine was significantly impaired in uninflamed jejuna of mice with colitis (Fig. 1C) .
DSS colitis reduced I Ca. We next examined whether the decrease in sympathetic neurotransmitter release during colitis was due to changes in the VGCC of SMG neurons. Intracellular Ca 2ϩ imaging of dissociated SMG neurons with fura 2-AM was used to examine the effect of colitis on depolarization-induced Ca 2ϩ influx in SMG neurons. Colitis significantly inhibited voltage-dependent Ca 2ϩ influx, measured as an increase in 340/380 ratios during 70 mM K ϩ -evoked depolarizations ( Fig. 2B ; P Ͻ 0.0001, Mann-Whitney test, n ϭ 41 neurons from control mice and 59 neurons from DSS-treated mice). In contrast, there was no significant difference in the unstimulated baseline 340/380 ratios of both groups (Control ϭ 0.51 Ϯ 0.02; DSS ϭ 0.57 Ϯ 0.03; n ϭ 31 each; P ϭ 0.2315, Mann-Whitney test), which indicates that resting intracellular Ca 2ϩ concentration was not affected during colitis. Perforated patch-clamp recording were utilized to further examine the effect of colitis on voltage-dependent I Ca in SMG. In control neurons, I Ca began to activate at approximately Ϫ35 mV and peaked at Ϫ10 mV with a maximum current density of 65.7 Ϯ 5.1 pA/pF (n ϭ 17) (Fig. 3) . I Ca was significantly smaller (P Ͻ 0.05; 2-way ANOVA with Bonferroni's post hoc test) in neurons from mice with DSS colitis (Fig. 3) . The maximum current density in neurons from mice with colitis was 29.3 Ϯ 2.4 pA/pF (n ϭ 19).
Current inhibition was restricted to N-type channels. After establishing that I Ca was reduced in SMG neurons from DSStreated mice, we utilized voltage-clamp techniques and channel blockers to determine whether the reduction was the result of a general inhibition of all voltage-gated Ca 2ϩ channel subtypes or was specific to a single class of channels. -Conotoxin GVIA-sensitive N-type current density was significantly reduced (control N-type current ϭ 31.3 Ϯ 4.9 pA/pF; DSStreated N-type current ϭ 7.0 Ϯ 1.6 pA/pF; P Ͻ 0.05, Student's unpaired t-test) by colitis, whereas the nifedipine-sensitive L-type current density was not affected (Fig. 4, A-C) . We next investigated whether a similar reduction in N-type channels during colitis occurred in sympathetic nerve terminals. The percent of colonic norepinephrine release during 70 mM K ϩ depolarizations that was sensitive to N-type channel blockade with -conotoxin GVIA was used to estimate the contribution of N-type channels to norepinephrine release. Similar to previous studies (8, 34, 53) , -conotoxin GVIA virtually abol- ished depolarization-induced norepinephrine release. However, the percentage reduction in release by N-type channel blockade was significantly smaller during colitis ( Fig. 4D ; n ϭ 6 for both groups; P ϭ 0.04; Mann-Whitney test). These results, along with those in Fig. 1B demonstrate that there was a decrease in norepinephrine release from inflamed colon and that the role of N-type channels in norepinephrine release was significantly reduced.
Voltage dependence of I Ca activation and inactivation. To investigate whether DSS treatment changed the voltage dependence of activation or inactivation of I Ca , voltage-clamp protocols were utilized as described earlier (see METHODS). There was no significant difference in the voltage dependence of inactivation between the two groups (Fig. 5A) . In contrast, the voltage dependence of activation was shifted to the right during colitis (Fig. 5B) . The consequence of this change in voltagedependent activation of I Ca is that a more depolarizing stimulus is required to activate these channels compared with control neurons and thus less calcium influx will occur following a depolarization. This in turn would reduce the amount of neurotransmitter released in response to a given stimulus.
Real-time PCR analysis of channel mRNA expression. Although the preceding experiments suggest that the kinetics of I Ca were altered during colitis they do not exclude the possibility that colitis also alters channel gene expression. We examined this possibility with quantitative real-time PCR and found that colitis significantly reduced expression of mRNA encoding the N-type channel alpha subunit, CaV2.2, relative to the housekeeping gene GAPDH (n ϭ 4 pairs of ganglia for each condition; P ϭ 0.02, Mann-Whitney test; Fig. 6 ).
DISCUSSION
The sympathetic innervation of the GI tract modulates motility, secretion, blood flow, and immune system activation (17, 31, 44, 50, 52) . Each of these functions is altered during IBD (4, 12, 25, 27) , as is the release of the sympathetic neurotransmitter norepinephrine (7, 20) . Accordingly, our aim here was to determine how colitis alters norepinephrine release. The major novel finding of this study is that reduced norepinephrine release in the GI tract during colitis is the consequence of N-type I Ca inhibition in prevertebral sympathetic neurons due to changes in channel gating and mRNA expression. Furthermore, inhibition of N-type I Ca and norepinephrine release was not restricted to neurons innervating the inflamed colon.
We previously investigated the contribution of VGCC subtypes to I Ca in SMG neurons and found that the main VGCC subtypes present on the membranes of SMG neurons were N-type (ϳ60%) and L-type (ϳ20%) (35) . These data are in agreement with the critical role of N-type VGCC in neurotransmitter release from sympathetic varicosities (8, 34, 53) . Given that N-type I Ca was selectively inhibited by colitis, and that the -conotoxin GVIA-sensitive release of norepinephrine was reduced during colitis (Fig. 4) , we propose that this may underlie dysfunctional sympathetic regulation of the GI tract during inflammation. CaV2.2 mRNA was reduced in the cell bodies of SMG neurons during colitis, which suggests that inflammation affects channel protein synthesis, thereby reducing the amount of N-type channels in sympathetic nerve terminals in the GI tract. examples of ICa in neurons from control (A) and DSS-treated (B) mice before and during superfusion with 300 nM -conotoxin GVIA followed by -conotoxin GVIA plus 10 M nifedipine. C: mean Ϯ SE inhibition of ICa by both 300 nM -conotoxin GVIA and 10 M nifedipine under control (-conotoxin GVIA, n ϭ 11; nifedipine, n ϭ 17) and DSS treatment (-conotoxin GVIA, n ϭ 14; nifedipine, n ϭ 11). *P Ͻ 0.05 vs. untreated controls, unpaired 2-tailed t-test. D: mean Ϯ SE percentage inhibition of colonic norepinephrine release by -conotoxin GVIA in control mice and mice with DSS colitis. *P ϭ 0.04; Mann-Whitney test; N ϭ 6 for both groups.
A previous study of the effects of TNBS-induced ileitis on celiac ganglion neurophysiology in guinea pigs reported increased excitability of tonic but not phasic neurons (14) . These data suggest that GI inflammation does not universally increase excitability in the celiac ganglion, in apparent contrast to our findings here of universal I Ca inhibition in the SMG during DSS colitis. However, neuronal excitability is determined by a number of ion channel types, including voltage-dependent K ϩ and Na ϩ channels, which are likely to be regulated separately from N-type Ca 2ϩ channels. Therefore, I Ca may be inhibited in the ileitis model without an effect on neuronal excitability. If this were the case, one might expect to observe a decrease in the amplitude of the Ca 2ϩ -dependent long afterhyperpolarizing potential (AHP) in the subset of neurons that have long lasting Ca 2ϩ -activated K ϩ channels. Dong et al. (14) reported a 27% decrease in AHP amplitude during ileitis; however, this inhibition did not reach statistical significance. Another important question that arises from the present study and that of Dong et al. is what the net effect of GI inflammation on sympathetic regulation of the GI tract is. The predicted consequence of enhanced excitability of tonic neurons from the celiac ganglion, which have been shown to negatively regulate the ENS (17), would be increased sympathetic regulation of the ENS during GI inflammation. However, several studies have demonstrated enhanced ENS activity (24, 26, 38) and decreased norepinephrine release (7, 19, 49) during GI inflammation. Thus it appears that despite, enhanced sympathetic neuronal hyperexcitability during GI inflammation, the inhibition of N-type Ca 2ϩ channels and resultant decrease in norepinephrine release during inflammation impairs sympathetic regulation of GI function.
It is noteworthy that colitis reduced I Ca in all SMG neurons, despite the fact that many SMG neurons innervate the small intestine and not the colon. These findings are similar to those of Dong et al. (14) on celiac ganglion neurons and contrast with dorsal root ganglion (DRG) neurons, since the only neurons in DRGs that were affected during TNBS ileitis were those that innervated the inflamed ileum (32, 43) . The authors of these studies suggested that the effects of GI inflammation on DRG neurons were due to exposure of peripheral terminals to the inflammatory milieu in the colon. However, our finding that the release of norepinephrine in the uninflamed jejunum is inhibited to the same extent as in the inflamed colon argues that direct exposure of sympathetic varicosities to inflammation may not entirely account for reduced norepinephrine release during colitis. Furthermore, our finding that colitis resulted in universal I Ca inhibition in SMG neurons, regardless of their axonal projections, indicates that current inhibition could be due to exposure of all SMG neuronal perikarya to elevated circulating cytokines, owing to the presence of fenestrated capillaries in the SMG (3, 11) .
We recently tested this hypothesis by examining the effect of TNF-␣, a proinflammatory cytokine that is implicated in IBD pathogenesis (21) , and found that overnight incubation of SMG neurons selectively inhibited N-type Ca 2ϩ channels (unpublished data). Our unpublished observations suggest that I Ca inhibition by TNF-␣ was due to activation of NF-B signaling, since inhibiting this pathway with SC-514 and Bay 11-7082 prevented I Ca inhibition by TNF-␣ (35) . We therefore attempted to reverse I Ca inhibition as a result of DSS colitis by culturing neurons from mice with colitis overnight in SC-514, but we saw no recovery of I Ca amplitude compared with vehicle-treated neurons (data not shown). However, these findings do not rule out a role for NF-B signaling in neuronal dysfunction during colitis, since the lack of effect of the inhibitor in vitro may be because NF-B inhibition can prevent but not reverse I Ca inhibition during colitis. Unfortunately, it was not feasible to examine whether NF-B inhibitors or neutralizing antibodies to TNF-␣ could prevent the decrease in I Ca during colitis, since these drugs interfere with colonic inflammation and systemic cytokine levels in the DSS model of colitis in mice (40, 42) . 
Mechanisms of N-type channel inhibition.
Voltage-gated Ca 2ϩ channels are exquisitely regulated on short time scales by voltage-and time-dependent inactivation, G protein-coupled receptor modulation, and on longer time scales by changes in gene transcription, mRNA stability, and channel subunit trafficking (9, 10, 13, 51) . We first examined whether the inhibition of N-type current during colitis was accompanied by changes in the voltage dependence of channel activation and inactivation. Colitis caused a rightward shift in the currentvoltage curve of I Ca activation compared with control neurons, which would result in a larger depolarizing stimulus being required to activate the VGCC of neurons from mice with colitis. In contrast, colitis did not affect the voltage dependence of inactivation of I Ca . These data may indicate that N-type channel phosphorylation status or interaction with G protein ␤␥ subunits (51) was altered by colitis, leading to a change in voltage-dependent channel activation.
We also examined whether colitis-induced inhibition of I Ca was related to changes in transcription of the genes related to the channels, as I Ca reduction persisted for 24 h after removal of neurons from animals with colitis. VGCC are composed of different subunits, including the pore-forming ␣1 subunit (22) . In accordance with the electrophysiological data which showed a reduction in N-type calcium current, we detected a significant reduction in CaV2.2 mRNA, which encodes the N-type channel ␣1 subunit. To our knowledge this is the first direct evidence that colitis can alter autonomic neuronal ion channel expression.
Potential significance. The present study provides strong evidence of changes in sympathetic VGCC during GI inflammation and identifies a possible mechanism for the reduction in sympathetic neurotransmitter release seen in animal models of IBD. One of the most consistent effects of colitis on the enteric nervous system is an overall hyperexcitability of the enteric nerve circuitry, including increased action potential discharge from enteric intrinsic primary afferent neurons and enhanced excitatory synaptic transmission (14, 16, 24, 26, 38, 41) . Given the inhibitory effects of the sympathetic nervous system on enteric microcircuits (6, 18) , it is tempting to speculate that the reduction of norepinephrine release during colitis may play a role in the dysfunction of the enteric nervous system during GI inflammation. In addition, colitis impairs sympathetic regulation of submucosal arterioles and mesenteric arteries (5, 27) , which may be a consequence of altered sympathetic neurotransmitter release and metabolism (36) . Given that ␤ 3 -adrenoceptors are protective in an animal model of IBD (52), reduced norepinephrine release due to N-type channel inhibition may directly contribute to the severity of inflammation by inactivating an endogenous anti-inflammatory pathway. Reversing the inhibition of VGCC and norepinephrine release during colitis may therefore ameliorate inflammation and reduce GI dysfunction.
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